Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII | NASDAQ

$10.20

$0.00 (0.00%)

At close: Oct 30, 2026, 3:59 PM ET

$10.19

-$0.01 (-0.10%)

After-hours: Oct 30, 2026, 4:02 PM ET

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024
Net Income	4.19M	-151.72K
Depreciation & Amortization	n/a	n/a
Stock-Based Compensation	n/a	n/a
Other Working Capital	105.11K	-42.58K
Other Non-Cash Items	-4.6M	n/a
Deferred Income Tax	n/a	n/a
Change in Working Capital	-607.65K	-42.58K
Operating Cash Flow	-1.02M	-194.3K
Capital Expenditures	n/a	n/a
Cash Acquisitions	n/a	n/a
Purchase of Investments	-500M	n/a
Sales Maturities Of Investments	n/a	n/a
Other Investing Acitivies	n/a	n/a
Investing Cash Flow	-500M	n/a
Debt Repayment	-533.78K	250.1K
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	n/a	n/a
Financial Cash Flow	501M	211.33K
Net Cash Flow	-16.81K	17.04K
Free Cash Flow	-1.02M	-194.3K
Adj. Free Cash Flow	-1.02M	-194.3K
Maintenance CapEx	n/a	n/a
Growth CapEx	n/a	n/a
Owner Earnings	-1.02M	-194.3K